RE:RE:RE:2 Questions for the board1% of a given population will use medical cannabis, so Germany has 80 million, so 800,000 patients heading up to 8.6 billion and over 50 billion in Europe. Keep in mind, Germany is looking at recreational as well. If you listen to ODI interview, they are being conservative and estimating .6% of the population in Poland will use medical cannabis. All we need is a slice of the pie. Aphria has not yet confirmed the quantity being shipped to Poland yet for ODI and we don't know about Germany either. Wait until we get EU GMP, I believe we will get a supply deal or JV. This will then justify our numbers, analysts raise targets as they finally can see the projections are real, and shorts fry (good earnings will help on top of this). Some numbers: https://www.dw.com/en/will-germany-become-the-worlds-largest-market-for-medicinal-cannabis/a-48112905
brentkosta wrote: Are yoGru aware of Any forecasted numbers or demand on ODI or Germany
gottahunch wrote: 1. This is where ODI in Poland and Germany come to play (with EU GMP which is coming shortly). I believe they will sell all they produce. Also, other LP's will fail and we will pick up market share in Canada. TRST already offline, likely ACB next as they are running out of 2. Not sure
brentkosta wrote: 1. Does APHA management have a plan to sell all the dry bud they are growing? I dont see that as possible.
2. Will any 2.0 sales be logged in this upcoming Q ending Nov 30th? THere must've been contract taken from OCS.